Nektar Therapeutics (NKTR) ticks all the boxes for top investors with its surprise performance of 30.14% last month.
On Monday, Nektar Therapeutics (NASDAQ: NKTR) was -2.78% down from the session before settling in for the closing price of $0.91. A 52-week range for